Limula raises $6.8m to accelerate cell therapy manufacturing platform
Swiss life science start-up, Limula, has secured $6.8m in seed funding to push forward its system for automating cell therapy manufacturing. Limula received CHF6.2M ($6.8m) to further advance the marketability of its device, comprising functionalities of …